Drug Report History #26870
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v4-FR | Version v2-FR |
|---|---|---|
| Language | French | French |
| Date Updated | 2018-12-28 (Updated) | 2017-10-24 |
| Drug Identification Number | 02299135 | 02299135 |
| Brand name | 40 (MEQ)MMOL/L POTASSIUM CHLORIDE PLUS 5% DEXTROSE & 0.9% CHLORURE DE SODIUM/SODIUM CHLORIDE INJECTION USP | 40 (MEQ)MMOL/L POTASSIUM CHLORIDE PLUS 5% DEXTROSE & 0.9% CHLORURE DE SODIUM/SODIUM CHLORIDE INJECTION USP |
| Common or Proper name | Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP 079109254 | Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP 079109254 |
| Company Name | HOSPIRA HEALTHCARE CORPORATION | HOSPIRA HEALTHCARE CORPORATION |
| Ingredients | DEXTROSE POTASSIUM CHLORIDE SODIUM CHLORIDE | DEXTROSE POTASSIUM CHLORIDE SODIUM CHLORIDE |
| Strength(s) | 5.0G 0.3G 0.9G | 5.0G 0.3G 0.9G |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 1000ML | 1000ML |
| ATC code | B05BB | B05BB |
| ATC description | I.V. SOLUTIONS | I.V. SOLUTIONS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2017-10-17 | 2017-10-17 |
| Actual start date | ||
| Estimated end date | 2017-11-30 | 2017-11-30 |
| Actual end date | 2017-11-30 (Updated) | |
| Shortage status | Resolved (Updated) | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | due to manufacturing issues | due to manufacturing issues |
| Health Canada comments |